ANIK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ANIK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-29), Anika Therapeutics's share price is $25.97. Anika Therapeutics does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.
The historical rank and industry rank for Anika Therapeutics's Price-to-Owner-Earnings or its related term are showing as below:
During the past 13 years, the highest Price-to-Owner-Earnings of Anika Therapeutics was 83.59. The lowest was 13.95. And the median was 27.90.
As of today (2024-04-29), Anika Therapeutics's share price is $25.97. Anika Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-5.65. Therefore, Anika Therapeutics's PE Ratio for today is At Loss.
As of today (2024-04-29), Anika Therapeutics's share price is $25.97. Anika Therapeutics's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.73. Therefore, Anika Therapeutics's PE Ratio without NRI for today is At Loss.
During the past 13 years, Anika Therapeutics's highest PE Ratio without NRI was 145.78. The lowest was 0.00. And the median was 22.78.
The historical data trend for Anika Therapeutics's Price-to-Owner-Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anika Therapeutics Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Price-to-Owner-Earnings | Get a 7-Day Free Trial | 36.75 | - | - | - | - |
Anika Therapeutics Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Price-to-Owner-Earnings | Get a 7-Day Free Trial | - | - | - | - | - |
For the Medical Instruments & Supplies subindustry, Anika Therapeutics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Anika Therapeutics's Price-to-Owner-Earnings distribution charts can be found below:
* The bar in red indicates where Anika Therapeutics's Price-to-Owner-Earnings falls into.
In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Anika Therapeutics's Price-to-Owner-Earnings for today is calculated as
Price-to-Owner-Earnings | = | Share Price | / | Owner Earnings per Share (TTM) |
= | 25.97 | / | -6.16 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anika Therapeutics (NAS:ANIK) Price-to-Owner-Earnings Explanation
For how to get Owner Earnings per Share (TTM), please click.
Thank you for viewing the detailed overview of Anika Therapeutics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.
Anne Nunes | officer: SVP, Chief Operations Officer | 32 WIGGINS AVENUE, BEDFORD MA 01730 |
Gary P Fischetti | director | 600 TECHNOLOGY PARK DRIVE, 4TH FLOOR, BILLERICA MA 01821 |
David Colleran | officer: EVP, General Counsel, Corp Sec | 600 TECHNOLOGY PARK DRIVE, SUITE 200, BILLERICA MA 01821 |
Cheryl R Blanchard | director | C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580 |
Michael L Levitz | officer: EVP, CFO, Treasurer | C/O ANALOGIC CORPORATION, 8 CENTENNIAL DRIVE, PEABODY MA 01960 |
Sheryl L Conley | director | C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN PA 19355 |
Henneman John B Iii | director | 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536 |
Raymond J Land | director | |
Stephen Richard | director | C/O ANIKA THERAPEUTICS, INC., 32 WIGGINS AVENUE, BEDFORD MA 01730 |
James Loerop | officer: EVP Business Development | C/O ACLARIS THERAPEUTICS, INC., 640 LEE ROAD, SUITE 200, WAYNE PA 19087 |
Sylvia Cheung | officer: CFO | ANIKA THERAPEUTICS, INC., 32 WIGGINS AVENUE, BEDFORD MA 01730 |
Glenn R. Larsen | director | 32 WIGGINS AVENUE, BEDFORD MA 01730 |
Joseph I Bower | director | 32 WIGGINS AVENUE, BEDFORD MA 01730 |
Jeffery S Thompson | director | 1140 HAVENBROOK COURT, SUWANEE GA 30024 |
Joseph G Darling | officer: President | 501 MANDALAY AVE., UNIT 409, CLEARWATER BEACH FL 33767 |
From GuruFocus
By PRNewswire PRNewswire • 02-21-2023
By sperokesalga sperokesalga • 02-28-2023
By sperokesalga sperokesalga • 04-13-2023
By Marketwired • 09-12-2023
By GuruFocus Research • 11-02-2023
By GuruFocusNews GuruFocusNews • 07-09-2022
By sperokesalga sperokesalga • 02-21-2023
By Value_Insider Value_Insider • 10-25-2022
By Marketwired • 08-08-2023
By Value_Insider Value_Insider • 11-01-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.